These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14494231)

  • 21. Pathogenesis of mouse hepatitis virus infection in gamma interferon-deficient mice is modulated by co-infection with Helicobacter hepaticus.
    Compton SR; Ball-Goodrich LJ; Zeiss CJ; Johnson LK; Johnson EA; Macy JD
    Comp Med; 2003 Apr; 53(2):197-206. PubMed ID: 12784855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse hepatitis virus type-2 infection in mice: an experimental model system of acute meningitis and hepatitis.
    Das Sarma J; Fu L; Hingley ST; Lavi E
    Exp Mol Pathol; 2001 Aug; 71(1):1-12. PubMed ID: 11502093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Attempts of neurotropization of the MHV3 virus (mouse hepatitis virus)].
    LAURIA D; VILLARI V; PARIANTE F
    Riv Ist Sieroter Ital; 1959; 34():473-81. PubMed ID: 14414590
    [No Abstract]   [Full Text] [Related]  

  • 24. Mouse hepatitis virus strain MHV-S: formation of pseudotypes with a murine leukemia virus envelope.
    Yoshikura H; Taguchi F
    Intervirology; 1978; 10(2):132-6. PubMed ID: 208999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against liver injury due to murine hepatitis virus.
    JUDAH JD; BJOTVEDT G; VAINIO T
    Nature; 1960 Aug; 187():507-8. PubMed ID: 14408055
    [No Abstract]   [Full Text] [Related]  

  • 26. Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis.
    Navas S; Seo SH; Chua MM; Das Sarma J; Lavi E; Hingley ST; Weiss SR
    J Virol; 2001 Mar; 75(5):2452-7. PubMed ID: 11160748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic pathology resulting from mouse hepatitis virus S infection in severe combined immunodeficiency mice.
    Huang DS; Emancipator SN; Fletcher DR; Lamm ME; Mazanec MB
    Lab Anim Sci; 1996 Apr; 46(2):167-73. PubMed ID: 8723232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptor-2 exacerbates murine acute viral hepatitis.
    Bleau C; Burnette M; Filliol A; Piquet-Pellorce C; Samson M; Lamontagne L
    Immunology; 2016 Oct; 149(2):204-24. PubMed ID: 27273587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience with mouse hepatitis virus sanitation in three transplantable murine tumour lines.
    Dagnaes-Hansen F; Horsman MR
    Lab Anim; 2005 Oct; 39(4):394-9. PubMed ID: 16197706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Absence of change in the concentration of the hepatitis virus inhibitor MHV 3 (Piazza's factor) in mice treated with a immunosuppressive drug (azathioprine)].
    Visconti M; De Marco F; Lista D; Pane G; Squame G
    Boll Soc Ital Biol Sper; 1972 Apr; 48(8):181-3. PubMed ID: 4341593
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the times of disappearance and re-appearance in the bone marrow and lymph nodes of MHV-3 hepatitis virus after intravenous inoculation in receptive mice].
    Lista D; Visconti M; De Marco F; Piazza M
    Boll Soc Ital Biol Sper; 1969 Mar; 45(6):323-5. PubMed ID: 4321459
    [No Abstract]   [Full Text] [Related]  

  • 33. Enhancement of the pathogenicity of mouse hepatitis virus (MHVI) by prior infection of mice with certain leukaemia agents.
    GLEDHILL AW
    Br J Cancer; 1961 Sep; 15(3):531-8. PubMed ID: 13899183
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of a murine hepatitis virus on the liver. An anatomic and histochemical study.
    JONES WA; COHEN RB
    Am J Pathol; 1962 Sep; 41(3):329-47. PubMed ID: 14452347
    [No Abstract]   [Full Text] [Related]  

  • 35. [Radioisotopes in experimental infection of laboratory animals with MHV 3 virus, NWS influenzal virus and with Trypanosoma brucei].
    De Dominicis A; Assumma M; Balestrieri A
    Arch Ital Sci Med Trop Parassitol; 1966; 47(7):199-210. PubMed ID: 4295330
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanism of cellular damage by virus: a study of antihistamine drugs. I. Murine hepatitis virus and liver explant cultures.
    VAINIO T; JUDAH JD; BJOTVEDT G
    Exp Mol Pathol; 1962 Feb; 1():15-26. PubMed ID: 13924199
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective action of drugs on the effects of murine hepatitis virus (MHV 3 ).
    Piplani SK; Aikat BK
    Indian J Pathol Bacteriol; 1971 Apr; 14(2):68-74. PubMed ID: 4402465
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction of lytic plaques by murine leukemia virus in murine sarcoma virus-transformed nonproducer mouse cells persistently infected with mouse hepatitis virus MHV-S.
    Yoshikura H; Taguchi F
    Intervirology; 1979; 11(2):69-73. PubMed ID: 218897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of enterotropic and polytropic mouse hepatitis virus in enzootically infected mouse colonies.
    Homberger FR; Zhang L; Barthold SW
    Lab Anim Sci; 1998 Feb; 48(1):50-4. PubMed ID: 9517890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotoxic effects of hexachlorobenzene on the pathogenesis of systemic, pneumonic and hepatic virus infections in the mouse.
    Carthew P; Edwards RE; Smith AG
    Hum Exp Toxicol; 1990 Nov; 9(6):403-11. PubMed ID: 2176797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.